Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
Background: Several promising new diagnostic methods and algorithms for tuberculosis have been endorsed by WHO. National tuberculosis programmes now face the decision on which methods to implement and where to place them in the diagnostic algorithm. Methods: We used an integrated model to assess th...
Main Authors: | Ivor Langley, MSc, Dr. Hsien-Ho Lin, MD, Saidi Egwaga, MD, Basra Doulla, MSc, Chu-Chang Ku, BS, Prof. Megan Murray, MD, Ted Cohen, MD, Prof. S Bertel Squire, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-10-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X14702918 |
Similar Items
-
Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa
by: Ivor Langley, et al.
Published: (2015-02-01) -
Is Cross-reactivity with Nontuberculous Mycobacteria a Systematic Problem in the Xpert MTB/RIF Assay?
by: Hee Jae Huh, M.D, et al.
Published: (2019-01-01) -
Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
by: Esther Ngadaya, et al.
Published: (2020-12-01) -
Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
by: Prof Anna Vassall, PhD, et al.
Published: (2017-07-01) -
Клиническая эффективность теста Xpert MTB/RIF
Published: (2015-07-01)